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Abstract
Significance: Over-nutrition and sedentary lifestyle has led to a worldwide increase in obesity, insulin resis-
tance, and type 2 diabetes (T2D) associated with an increased risk of development of cardiovascular disorders.
Diabetic cardiomyopathy, independent of hypertension or coronary disease, is induced by a range of systemic
changes and may through multiple processes result in functional and structural cardiac derangements. The
pathogenesis of this cardiomyopathy is complex and multifactorial, and it will eventually lead to reduced
cardiac working capacity and increased susceptibility to ischemic injury. Recent Advances: Metabolic dis-
turbances such as altered lipid handling and substrate utilization, decreased mechanical efficiency, mitochon-
drial dysfunction, disturbances in nonoxidative glucose pathways, and increased oxidative stress are hallmarks
of diabetic cardiomyopathy. Interestingly, several of these disturbances are found to precede the development of
cardiac dysfunction. Critical Issues: Exercise training is effective in the prevention and treatment of obesity and
T2D. In addition to its beneficial influence on diabetes/obesity-related systemic changes, it may also amend
many of the metabolic disturbances characterizing the diabetic myocardium. These changes are due to both
indirect effects, exercise-mediated systemic changes, and direct effects originating from the high contractile
activity of the heart during physical training. Future Directions: Revealing the molecular mechanisms behind
the beneficial effects of exercise training is of considerable scientific value to generate evidence-based therapy
and in the development of new treatment strategies. Antioxid. Redox Signal. 22, 1587–1605.
Introduction
The world is facing an epidemic increase in obesity andinsulin resistance due to over-nutrition and sedentary life-
style. Obesity and insulin resistance are risk factors for type 2
diabetes (T2D), and cardiovascular disease is the leading cause
of mortality in patients with T2D. In addition to increased in-
cidence of hypertension and concomitant macro- and micro-
vascular disorders, diabetic patients are also at risk of developing
a specific diabetic cardiomyopathy (66). The development of
diabetic cardiomyopathy is most likely induced by a range of
systemic changes, which through multiple signaling pathways
will lead to functional and structural derangements (Fig. 1).
Hallmarks of the diabetic heart include oxidative stress,
fibrosis, apoptosis, impaired autophagy, inflammation, and
altered calcium handling. In addition, these hearts display
metabolic-related changes, including altered substrate utili-
zation, decreased mechanical efficiency, lipid accumulation,
mitochondrial dysfunction, impaired insulin signaling, in-
creased advanced glycation end-products (AGEs), and sus-
tained O-linked N-acteylglucosamine (O-GlcNAc)
modification of proteins. The pathogenesis of this cardio-
myopathy is, by no doubt, multifactorial and complex,
eventually leading to an energetically compromised heart
with reduced working capacity and increased susceptibility to
ischemia-reperfusion.
Aerobic fitness, measured as maximal oxygen uptake
(VO2max), has been shown to be a strong and independent
predictor for total and cardiovascular mortality both in healthy
individuals and in patients with cardiovascular disease (109,
144). Exercise is a low-cost strategy for prevention and
treatment of obesity and T2D (120, 207). It is well known that
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exercise can induce cardioprotection in normal hearts through
a range of molecular mechanisms (79, 158). Beneficial cardiac
effects after exercise training in diabetes/obesity have been
reported in clinical (94, 167, 172, 173) and experimental ani-
mal studies (21, 61, 85, 111, 128, 176, 184). This review
highlights existing knowledge of how metabolic derangements
contribute to the development of diabetic cardiomyopathy, and
of how exercise training may influence these changes and the
progression of diabetic cardiomyopathy.
Myocardial Substrate Utilization in Diabetes
The requirement to continuously pump blood makes the
myocardium the most metabolically active tissue in the body.
The majority of its ATP production is derived from mito-
chondrial oxidative phosphorylation (OxPhos), and to meet
the high energetic demand, a constant flow of substrate to the
mitochondria is pivotal. The cardiac metabolic network has
developed a versatile system, capable of metabolizing all
carbon substrates for energy production, where glucose and
fatty acids (FA) are the main substrates (Fig. 2). An important
feature of the normal heart is metabolic flexibility and the
ability to ensure appropriate ATP production rate under di-
verse physiologic and dietary conditions. Lack of this flexi-
bility has been regarded as fundamental in the development
of heart failure, including diabetic cardiomyopathy, but ex-
actly how remains unclear.
Despite the presence of hyperglycemia, the diabetic heart
relies predominantly on FA oxidation, with a concomitant
reduction in glucose oxidation (1, 17, 155). Obesity and
diabetes-induced enhancement of myocardial FA uptake and
oxidation is due to the activation of peroxisomal proliferator-
activated receptor-a (PPAR-a) and, consequently, transcrip-
tional induction of enzymes involved in FA transport and
b-oxidation. This also leads to a concomitant suppression of
glucose oxidation, due to increased expression of pyruvate
dehydrogenase kinase 4 (PDK4), which inhibits the pyruvate
dehydrogenase complex (PDH) (129). Recent studies in
skeletal muscle have also suggested carnitine acetyl-
transferase (CrAT) to be a key regulator in metabolic flexi-
bility, and that deficits in CrAT activity in diabetes might
contribute to a more rigid and inflexible metabolism (140).
Altered cardiac substrate metabolism has been shown in
experimental and clinical studies to precede the development
of ventricular dysfunction (1, 155). Studies using genetically
modified mice in which cardiac FA uptake and/or oxidation
resemble that of the diabetic metabolic phenotype also de-
scribe development of cardiac dysfunction (48, 49, 67), and
interventions that reduce the substrate switch have been
shown to ameliorate the development of ventricular dys-
function (17, 81, 96).
Taken together, these studies support the notion that altered
myocardial lipid metabolism has a causative role in diabetic
cardiomyopathy and that targeting myocardial metabolism is
a therapeutic intervention for the maintenance of cardiovas-
cular health in diabetes (129). It should be noted, however,
that the presence of FAs or maintenance of FA oxidation has
also been reported to have beneficial functional effects in
diabetic hearts and cardiomyocytes (64, 88, 191, 203). These
discrepancies may suggest that while preventing the switch in
substrate utilization may ameliorate the development of dia-
betic cardiomyopathy, diabetic hearts in an untreated state
may undergo adaptive changes that eventually make these
hearts dependent on FAs, specifically as an energy substrate.
Endurance training improves myocardial metabolism
An acute exercise session will lead to an altered metabolic
state with high levels of plasma lactate (from glycolysis in
exercising muscle) and nonesterified FAs (b-adrenergic
stimulation and lipolysis). Consequently, FA and lactate
become the major substrates for the heart during exercise
(76). The myocardial metabolic adaptation in response to
endurance training is, however, less clarified. Several studies
have reported altered expression of genes and proteins related
to myocardial metabolism in normal (83, 126, 185) and di-
abetic hearts (85, 177) in response to chronic exercise. Stu-
dies directly addressing the effects of exercise training on
metabolic fluxes in the hearts are, however, few and diverging.
In the normal heart, Broderick et al. (37) did not find tread-
mill running to alter myocardial glucose oxidation and gly-
colysis, whereas Burelle et al. (39) reported an increased rate
of both glucose and FA oxidation while glycolysis was de-
creased. These discrepancies may be related to variations in
the intensity of the exercise training protocol and in line with
this, Hafstad et al. (83) recently reported that only high-
intensity training (and not moderate intensity) altered myo-
cardial substrate utilization in normal mice.
In type 1 diabetic (T1D) rats, induced by streptozotocin
(STZ), exercise training was reported to increase rates of
glucose oxidation and glycolysis (37) whereas FA oxidation
was unaltered (153). Similarly, in a recent study using diet-
induced insulin-resistant mice, treadmill running increased
myocardial glucose oxidation while oxidation rates of FAs
were less affected (85). An important finding from the latter
study was that in contrast to that reported in healthy mice,
both high- and moderate-intensity training induced a similar
metabolic response in obese mice.
FIG. 1. Hallmarks of diabetic cardiomyopathy. A range
of systemic changes contribute to the onset of molecular
mechanisms leading to cardiac dysfunction and inefficiency
in diabetes. NO, nitric oxide; AGE, advanced glycation-end
product; RAGE, AGE receptors; ROS, reactive oxygen
species; RAS, renin-angiotensin system; LV, left ventricle;
O-GlcNAc, O-linked N-acteylglucosamine.
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Evidence from studies on skeletal muscle has shown that
exercise training can influence insulin pathways and improve
insulin resistance. Insulin signaling seems to have a central
role in the exercise-induced hypertrophic response in the
healthy heart (164). Exercise has also been shown to increase
the ability of insulin to phosphorylate the insulin receptor
(IR), insulin receptor substrate-1 (IRS-1), IRS-2, Akt, and
Foxo1, as well as to affect other pathways influencing the
insulin signaling cascade in cardiac tissue from diet-induced
obese rats (134, 157). The metabolic consequence (i.e.,
substrate utilization) of these changes has, however, not been
investigated. It should be noted that compelling experimental
evidence has linked excessive cardiac insulin signaling with
adverse effects after chronic pressure overload in normal and
T1D (180), implying that improved systemic insulin levels by
exercise training may provide beneficial cardiac effects under
certain types of stress, such as hypertension.
Diabetes-Induced Hyperglycemia Stimulates
Nonoxidative Glucose Pathways in Diabetic
Cardiomyopathy
Hyperglycemia is an important risk factor for developing
cardiovascular disease. In addition to generating pyruvate for
oxidation, elevated plasma levels of glucose may also affect
nonoxidative glucose pathways (Fig. 3). Both intracellular
and extracellular lipids and protein exposed to high levels of
sugars may become irreversibly glycated and form AGEs.
AGE modifications of the extracellular matrix may render the
tissue less compliant and induce myocardial stiffness (43).
AGEs can also bind to AGE receptors (RAGEs), which may
activate redox-sensitive transcription factors, such as nuclear
factor-jB (NF-jB), and, consequently, affect intracellular
signaling pathways leading to remodeling of the extracellular
matrix, cell growth, cytokine formation, increased produc-
tion of reactive oxygen species (ROS), and reduced nitric
oxide (NO) bioavailability (80).
There is substantial evidence that AGEs are key mediators
in the development of vascular injury in diabetic patients
(80), and recent studies also support the role of AGEs and
RAGEs in the development of diabetic cardiomyopathy (43,
114). In STZ-induced diabetes, treatment with the AGE
cross-link breaker ALT-711 was shown to reduce cardiac
AGEs, accompanied by a normalization of collagen III de-
position, improvement of calcium handling, and attenuation
of diabetes-associated myocardial structural changes (43,
114). The soluble form of RAGE (sRAGE), lacking an in-
tracellular domain, is believed to work as a scavenger for
AGE (205). In diabetic patients, an inverse correlation has
been reported between plasma levels of sRAGE and HbA1c,
insulin resistance index, and C-reactive protein (13).
The polyol pathway, which branches off the glycolytic
pathway, is activated after increased concentrations of intra-
cellular glucose. Aldose reductase (AR, the rate-limiting step of
this pathway) oxidizes NADPH to NADP and can thus impair
myocardial reductive/antioxidant capacity. Introducing hy-
perglycemia to isolated hearts has been shown to increase ac-
tivation of the polyol pathway, accompanied by increased
oxidative stress and impaired left ventricular diastolic function,
while inhibition of AR attenuated these changes (188). In-
creased AR activity has been demonstrated in T1D hearts
(105), while reports from T2D models are lacking.
Hyperglycemia can also increase the synthesis of dia-
cylglycerol (DAG), an activator of the protein kinase C
(PKC) signaling pathway in the diabetic heart (104). In-
creased activity of this pathway is associated with cardiac
hypertrophy, fibrosis, adverse Ca2 + handling, and reduced
cardiac performance (197). Treatment with a PKCb inhibitor
has been found to reduce collagen deposition, increase
SERCA2a expression, and preserve diastolic function in T1D
hearts (54).
Elevated intracellular glucose may also increase flux of
carbons from glucose through the hexosamine biosyn-
thetic pathway (HBP). This produces uridine diphosphate
N-acetylglucosamine (UDP-GlcNAc), which is used as a
substrate by O-GlcNAc transferase to modify serine/threonine
residues in proteins (206). O-GlcNAcylation is reported to be
upregulated in obese and diabetic hearts (19, 56, 97, 135).
Although O-GlcNAcylation of proteins integrates glucose
metabolism with posttranslational modifications, this process
is not simply regulated by substrate availability, as multiple
stressors have also been shown to induce O-GlcNAcylation
in cardiac tissue (47, 198, 199).
Altered O-GlcNAcylation may influence many of the pro-
cesses known to be affected in diabetic cardiomyopathy,
including mitochondrial respiratory capacity (98), insulin
signaling (89), FA utilization (118), Ca2 + handling (63, 97),
autophagy (131), ER stress (147, 198), and fibrosis (3). Protein
O-GlcNAcylation seems, however, to be paradoxical in nature;
while a reduction in the overall O-GlcNAcylation in diabetic
hearts is beneficial in terms of Ca2 + handling and ventricular
function (97, 133), and O-GlcNAcylation has also been re-
ported to be fundamental in cardiac protection (47, 125, 147,
199). This has led to the suggestion that acute elevation of
cardiac protein O-GlcNAcylation is protective, while sustained
protein O-GlcNAcylation is detrimental (103).
Exercise training reduces nonoxidative
glucose pathways
Given the beneficial effects of exercise on glycemic control
(85, 190, 200), one would expect that this should amend the
adverse effects of the increased nonoxidative glucose path-
ways in the diabetic heart (Fig. 3). Interestingly, studies ad-
dressing these pathways often report exercise-induced effects
that are independent of systemic effects (19, 29, 136). As ex-
ercise training also increases myocardial glucose oxidation
(85), this may be a mechanism contributing to the shunting of
carbons away from nonoxidative glucose pathways.
Although reports on cardiac effects of exercise on the
RAGE/AGE system are sparse, exercise has been found to
reduce fibrosis together with reduced AGEs in the ventricles of
aged rats (202). In T2D patients, exercise training increased
plasma levels of sRAGE, associated with reduction of several
cardiometabolic risk factors (50). However, in obese Zucker
rats, exercise lowered plasma AGEs without affecting circu-
lating glucose, insulin, lipid profile, oxidative status, or in-
flammatory markers (29). Exercise training has also been
shown to ameliorate the obesity-induced activation of both the
NF-jB and JNK pathways in the heart (134), supporting an
anti-inflammatory effect of exercise in cardiac tissue (30),
which could potentially work through AGE pathways.
The role of the polyol pathway or PKC pathway in exercise-
attenuated insulin resistance and cardiac dysfunction in
EXERCISE-INDUCED EFFECTS IN THE DIABETIC HEART 1589
diabetes remains unclear. The exercise-induced reduction in
myocardial DAG levels has been associated with improved
left ventricular function in T1D rats, although this was not
found to be associated with altered PKCbII protein expres-
sion or activity (128).
Long-term intensive swim-training has been reported to
reduce total cardiac protein O-GlcNAcylation in both lean
mice (15) and STZ mice (19). In db/db mice, however,
treadmill running was found to increase cardiac protein O-
GlcNAcylation (56). A plausible explanation for these find-
ings may be the use of different experimental models,
training modes, and intensities. Recently, it has been dem-
onstrated that acute exercise training altered cardiac protein
O-GlcNAcylation in a very time- and spatial-restricted
manner without any change in overall O-GlcNAc protein
levels (136). This suggests a complex regulation of cardiac
O-GlcNAcylation in response to exercise and may also par-
tially clarify the discrepancies in the studies addressing car-
diac protein O-GlcNAcylation after exercise interventions.
Lipotoxicity in Diabetic Cardiomyopathy
As a consequence of excess cardiac FA uptake relative to
oxidation, long-chain FAs are incorporated into triacylgly-
cerols (TAG), leading to cardiac steatosis in diabetes/obesity
(85, 165). Elevated intramyocellular TAG content in skeletal
muscle, in the absence of exercise, is a strong predictor of
global insulin resistance (139), and intramyocardial TAG
accumulation has been found to be an independent predictor
of cardiac dysfunction in T2D patients (165).
Although TAG is not regarded as a toxic molecule in itself,
shunting of FAs into nonoxidative pathways can lead to ac-
cumulation of intermediate metabolites, including DAG and
ceramides at high concentrations (Fig. 2), and may increase
fibrosis through the activation of protein kinases (PKCb
or PKA) (10), induce apoptosis (151), and disrupt insulin
signaling (208). In addition, long-chain acylcarnitines and
acyl-CoAs accumulate in skeletal muscle in diabetes due to
incomplete b-oxidation and impaired CrAT activity (175).
This has fostered support for a lipid-induced insulin resis-
tance associated with obesity (113, 140).
Accumulation of mitochondrial long-chain acylcarnitine
was also shown to impair glucose metabolism in the heart
(130). Furthermore, shunting of lipid intermediates into TAG
in lipid droplets has been shown to ameliorate ventricular
dysfunction in models of lipotoxicity by maintaining a low
concentration of lipotoxic intermediates (126, 127). In this
regard, Perilipin-5 (Plin-5) is believed to play an important
role in the stabilization and facilitation of lipolysis in the
cardiomyocyte and in the direct transfer of FA between lipid
droplets and mitochondria (Fig. 3) (115). Interestingly, al-
though Plin-5 knockout mice showed a decline in cardiac
function with age, they were resistant to STZ-induced cardiac
dysfunction (116). These findings suggest that the diabetic
heart may undergo adaptations, enabling them to cope with
elevated lipid supply.
The effects of exercise on myocardial lipotoxicity
In healthy individuals, an acute bout of exercise can in-
crease cardiac lipid content through exercise-induced eleva-
tion of FA concentrations in the blood (22). In normal mice,
increased cardiac TAG storage after short-term intensive
swim training was found to be accompanied by a marked
upregulation of the TAG storage enzyme diacylglycerol
transferase 1 (DGAT1), whereas the level of ceramide and
DAG was reported to be reduced (126) (Fig. 2).
In obese subjects, endurance/strength training was shown
to reduce myocardial TAG content in combination with im-
proved ejection fraction (172). This finding, however, was
FIG. 2. Glucose and FA uptake and oxidation in the
diabetic cardiomycyte. A continuous elevation in FAs
supply leads to increased long-chain FA (LCFA) utilization
due to activation of the peroxisome proliferator-activated
receptor (PPAR)-a and, consequently, transcriptional in-
duction of enzymes involved in FA transport (FAs transport
protein [FATP], FA binding protein [FABP] and FA trans-
locase [FAT/CD36]) and b-oxidation (b-ox). The entry of
Acyl-CoA into the mitochondria is mediated by the
carnitine-palmitoyltransferase (CPT1 and 2) system. After
b-oxidation, acetyl Co-A enters the tricarboxylic acid
(TCA) cycle to form reducing equivalents (FADH2/NADH)
that drive the electron transport chain (ETC) and generate
the proton motive force that powers ATP synthesis. Glucose
uptake (facilitated diffusion by the glucose transporters 1
(GLUT1) and the insulin-sensitive GLUT4) are decreased in
diabetes due to impaired insulin signaling. Pyruvate formed
from glycolysis is taken up by the mitochondria, and acetyl-
CoA is generated by the pyruvate dehydrogenase complex
(PDH). Myocardial glucose oxidation is reduced in diabetes
due to increased pyruvate dehydrogenase kinase 4 (PDK4),
which inhibits the PDH. Excess acyl-CoA is stored as tria-
cylglycerol (TAG) in lipid droplets and may result in the
accumulation of toxic intermediates such as diacylglycerol
(DAG) and ceramides. Impaired mitochondrial respiration
may be due to reduced respiration capacity and/or efficiency,
increased uncoupling via uncoupling proteins (UCP), and/or
the adenine nucleotide translocase (ANT). Exercise-induced
changes reported in the literature are indicated by stars and
described in detail in the text. See ‘‘Myocardial Substrate
Utilization in Diabetes’’ and ‘‘Lipotoxicity in Diabetic Car-
diomyopathy’’ sections for references. DGAT, diglyceride
acyltransferase; MCD, malonyl-CoA decarboxylase; ACC,
acetyl-CoA carboxylase; Plin-5, perilipin-5.
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not reproduced in obese T2D patients where myocardial TAG
contents were found to be unaltered (107, 173). Exercise-
induced reduction in myocardial TAG content has been re-
ported in diet-induced obese mice (85), while the effects on
myocardial DAG and ceramides levels in obese/diabetic
models are not known. Although increased Plin-5 expression
has been reported after acute exercise in human skeletal
muscle (112), the effects of exercise on Plin-5 in the heart
remain to be elucidated.
Mitochondrial Disturbances in Diabetic
Cardiomyopathy
The heart is highly dependent on mitochondrial OxPhos,
which must be closely linked to the rate of ATP hydrolysis.
Mitochondrial dysfunction has been suggested to play a
central role in the pathogenesis of diabetic cardiomyopathy,
as an imbalance between energy availability and demand will
lead to an energetically compromised heart with reduced
working capacity. In human diabetic atria fibers, Anderson
et al. (5) found that ADP-stimulated respiration (state 3 res-
piration) was decreased when using both palmitate and glu-
tamate as substrates. In experimental studies from obese/
diabetic models, decreased and unchanged mitochondrial re-
spiratory capacity has been reported using carbohydrate-based
substrates (2, 14, 32, 33, 53, 68, 85), while there is less agree-
ment when FAs are used as substrates (2, 14, 31–33, 53, 68).
Mitochondrial uncoupling is regarded as a key mediator of
mitochondrial dysfunction in the diabetic heart. The under-
lying mechanisms mediating diabetes-induced uncoupling
are unclear, but both uncoupling proteins (UCPs) (31, 33,
142) and adenine nucleotide translocator (33) have been
proposed as candidates. Although there are inconsistent
findings regarding the gene and protein expression of myo-
cardial UCPs in models of T2D (32, 142), UCP activity is
known to be increased by FAs, ROS, and lipid peroxidation
products (60). Recent studies have demonstrated that both
inhibition (53, 141) and genetic deletion (31) of UCP3 im-
prove P/O ratios in models of diet-induced obesity.
The coupling efficiency of diabetic mitochondria evalu-
ated by respiratory control ratio (i.e., RCR or state 3/state 4)
or P/O ratio (a measure independent of the oxygen con-
sumption) is decreased or unchanged in diabetic conditions
(31–33, 53, 85, 142). Finally, mitochondrial respiration
after administration of oligomycin (an inhibitor of ATP
synthase) has also in some cases been reported to be in-
creased (32, 33). Although the role of this proton leak is
unclear, it has been suggested to lower mitochondrial
membrane potential and, subsequently, reduce mitochon-
drial ROS production. Further research is, however, re-
quired to better elucidate the precise physiological role and/
or the pathophysiological consequence of mitochondrial
uncoupling in the heart.
Increased mitochondrial mass, area, and number have been
reported in diabetic hearts (178, 179), possibly as an adaptive
mechanism to overcome impaired mitochondrial respiratory
capacity. In line with this notion, Shen et al. (178) found in
hearts from T1D mice that improving the antioxidant ca-
pacity amended mitochondrial respiration, which was ac-
companied by normalization of mitochondrial density and
morphometry (178).
Calcium is an important activator of key metabolic en-
zymes in the mitochondria (168) and accelerates the pro-
duction of NADH (34). Mitochondrial Ca2 + cycles via the
uniporter entry and export system (12, 168) and will be
influenced by changes in cytosolic Ca2 + homeostasis. De-
pression of mitochondrial Ca2 + uptake and handling has
been reported in diabetic cardiomyocytes (65, 156), as a
consequence of impaired Ca2 + handling (as will be discussed
later), and is therefore a plausible contributing factor to im-
paired energy metabolism in diabetic cardiomyopathy. Mi-
tochondria can also induce cell necrosis via opening of the
Ca2 + -sensitive permeability transition pore (mPTP). Several
studies have shown that mitochondria from diabetic hearts
are sensitized to mPTP opening (6, 182), which may be partly
responsible for the increased susceptibility to ischemic injury
described in diabetic hearts.
FIG. 3. Nonoxidative pathways in diabetic cardiomy-
opathy and proposed effects of exercise training. Hy-
perglycemia and reduced shunting of carbons from
glycolysis into glucose oxidation may lead to the induction
of nonoxidative glucose pathways, including the polyol,
hexosamine biosynthetic (HBP), protein kinase C (PKC),
and advanced glycation end-products (AGE) pathway in the
diabetic heart. Increased plasma levels of AGEs can also
bind to AGE receptors (RAGEs), which together with PKC
and oxidative stress are known activators of nuclear factor-
jB (NF-jB). Increased NF-jB activity together with these
pathways may mediate adverse effects in the diabetic heart
due to impaired myocardial reductive capacity, formation of
AGEs, and sustained O-GlcNAcylation of proteins. Exercise
training may, through improved glucose homeostasis and
increased myocardial glucose oxidation, reverse the induc-
tion of several nonoxidative glucose pathways in the dia-
betic heart. In addition, exercise can increase plasma levels
of the soluble form of RAGE (sRAGE), which may work as
a scavenger for AGEs and therefore reduce the intracellular
effects of AGE/RAGE signaling. See ‘‘Diabetes-Induced
Hyperglycemia Stimulates Nonoxidative Glucose Pathways
in Diabetic Cardiomyopathy’’ section for references.
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The effect of exercise on mitochondrial function
Increased palmitoyl-carnitine and glutamate supported res-
piration capacity has been demonstrated after exercise train-
ing in cardiac mitochondria from normal (83, 148) and obese/
diabetic rodent models (68, 85). Exercise-mediated improve-
ment in mitochondrial capacity may be linked to mitochon-
drial Ca2 + handling. Although this has not been specifically
studied, there could be an obvious link between enhanced mi-
tochondrial calcium handling in diabetes and the beneficial
effects on mitochondrial respiratory capacity and efficiency
observed in hearts from endurance trained diabetic models
(68, 85, 148).
Hafstad et al. (85) did not find exercise training to improve
RCR, but to normalize P/O ratios, which was accompanied by
increased proton leak after inhibition with oligomyocin. This
may suggest that the mitochondrial adaptations induced by
endurance training compensate for mild mitochondrial proton
leak and preserve the efficiency of ATP synthesis. Interest-
ingly, similar mitochondrial changes were recently reported in
skinned cardiac fibers from high-fat-fed UCP3KO mice (31).
The impact of exercise training on mPTP opening remains
largely unknown. Targeted treatment to reduce mitochon-
drial ROS was shown to improve resistance to mPTP opening
in diabetic hearts (182). One could therefore speculate that
exercise-induced effects on mitochondrial redox environ-
ment (as will be discussed later) may potentially increase
resistance to mPTP opening in the diabetic heart and, con-
sequently, increase cell survival in response to insults such as
ischemia or Ca2 + overload.
Although exercise training has been shown to induce mi-
tochondrial biogenesis in skeletal muscle (83, 123), its effect
on mitochondrial biogenesis in the heart is less clear. In a study
using lean mice, it was demonstrated that exercise induced
skeletal muscle but not cardiac mitochondrial biogenesis
(123). In contrast, high-intensity interval training was reported
to increase cardiac mitochondrial content both in lean (83) and
in obese (85) animal models. Interestingly, the same studies
reported that this was not found after moderate-intensity
continuous training (83, 85), suggesting a role of intensity in
exercise-induced cardiac mitochondrial biogenesis.
Sources of ROS and Their Roles in the Progression
of Diabetic Cardiomyopathy
Apart from being the final electron acceptor in electron
transport chain (ETC), oxygen plays a role in cellular redox
signaling, and may become toxic through formation of high
concentrations of ROS. Thus, redox modulation of cellular
proteins comes in ‘‘different flavors’’; while moderate re-
versible oxidations may increase protein activity, and a more
sustained ROS may induce pathological modifications through
stable interactions with lipids, proteins, and DNA (40).
Several systemic alterations (Fig. 4) are believed to con-
tribute to increased ROS formation in diabetes and obesity. In
particular, the cardiovascular system is characterized by in-
creased mitochondrial and extra-mitochondrial ROS genera-
tion as well as by impaired antioxidant defense systems (5, 33,
77, 162). Clinical and experimental studies support increased
oxidative damage in diabetes (5, 33, 191, 195), and oxidative
stress is likely to be a key mediator in the pathogenesis of
diabetic cardiomyopathy and to be causative for the increased
ischemic susceptibility in the diabetic heart (42, 57).
Despite substantial evidence from experimental studies
showing beneficial cardiac effects of different pharmacologi-
cal and genetic antioxidant therapies (124, 178, 189, 204),
clinical trials have failed to show beneficial effects of con-
ventional antioxidant therapies (24). A plausible explanation
for these discrepancies is that general exogenous antioxidant
therapies target all sources of ROS, not only pathophysiolog-
ical ROS but also physiological ROS signaling in the heart.
In hearts from both humans (5) and animal models (33, 64,
191), a high rate of mitochondrial ROS generation is believed
to contribute to diabetes-induced mitochondrial dysfunction.
In accordance, Shen et al. (178) demonstrated that cardiac
overexpression of the mitochondrial antioxidant manganese
superoxide dismutase (MnSOD) was able to reduce ROS and
normalize mitochondrial function.
Mitochondrial ROS production in diabetes is suggested to
be due to an increased supply of reducing equivalents from
myocardial FA oxidation to the ETC, without a parallel in-
crease in the OxPhos capacity. The subsequent loss of elec-
trons from the ETC leads to the generation of superoxide
(O2
 - ) at complex I and II. This notion has been challenged
by Fauconnier et al. (64), who found that although palmitate
profoundly increased mitochondrial ROS production in wild-
type cardiomyocytes, this was not observed in cardiomyocytes
FIG. 4. Myocardial ROS producing systems in diabetes
and the effect of exercise training. Systemic changes in
diabetes such as increased levels of angiotensin II (Ang II),
insulin, cytokines, glucose, and dyslipidemia may induce
the production of reactive oxygen and nitrogen species
(RONS) from both mitochondrial and nonmitochondrial
sources, including NADPH oxidases (NOX), xanthine oxi-
dase (XO), and nitric oxide synthase (NOS). Reactive ox-
ygen species may also lead to the uncoupling of endothelial
NOS (eNOS), which will decrease NO production, limiting
its bioavailability. These changes can lead to several adverse
effects in the diabetic myocardium, which can be amelio-
rated through the systemic effects of exercise. Direct effects
of exercise on ROS-producing enzymes are also reported
and described in the text.
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from ob/ob mice. In addition, Tocchetti et al. (191) recently
found that palmitate restored redox balance and counteracted
the exaggerated ROS emission induced by hyperglycemia
and b-adrenergic stimulation in isolated cardiomyocytes
from db/db mice. Again, this suggests a complex role for FAs
in the diabetic heart and the possibility that an adaptive re-
sponse in diabetic mitochondria allows them to maintain
homeostasis in the presence of high FAs.
A major nonmitochondrial source of ROS in cardio-
myocytes are NADPH oxidases (NOXs) that produce ROS
by using reducing equivalents from NADPH to molecular
oxygen. NOX2 and NOX4 are the main isoforms in the
cardiomyocyte, and their activation may modulate multiple
signaling pathways and redox-sensitive proteins (7, 8).
NOX signaling has been shown to influence hypertrophic
pathways, fibrosis, cell viability, calcium handling, ER
stress, and antioxidant capacity (40, 86, 145, 170). Potent
activators of NOXs are angiotensin II, hyperglycemia, cy-
tokines, oxidized low-density lipoprotein, mechanical for-
ces, and hypoxia (8, 145). Interestingly, the two isoforms
differ in mode of activation, subcellular location and they
mediate distinct redox responses to agonist stimulation (8).
NOXs have been shown to play key roles in the patho-
genesis of vascular disease in diabetes (74), and in the
myocardium increased expression of NOXs has been found
in type 1 and T2D models (72, 195). Both genetic and
pharmacological inhibition of NOX2 has been found in T1D
mice to reduce myocardial fibrosis, improve ER stress
markers and cardiac function (122). Furthermore, treatment
of T2D rodents with an angiotensin receptor blocker was
found to reduce the cardiac expression of NOX2 together
with reduced cardiac ROS and fibrosis (72, 195).
NO produced by different NO synthase (NOS) isoforms,
working in discrete subcellular domains to induce S-
nitrosylation, may alter the activity of proteins involved in
physiological processes such as excitation-contraction (EC)
coupling (174), b-adrenergic inotropic response (78), and
also the Frank–Starling mechanism (159). However, under
conditions of increased ROS, endothelial NOS (eNOS) may
become uncoupled (45) and produce O2
 - , which can react
with inducible NOS (iNOS)-produced NO to form highly
oxidant reactive nitric species.
Hyperglycemia favors iNOS expression in normal hearts
(46), and in the diabetic myocardium an increased monomer-
to-dimer ratio of eNOS leads to production of O2
 - (209).
Reduced NO bioavailability, increased nitrosative stress, and
peroxynitrite formation are believed to contribute to the
pathogenesis of vascular disease in diabetes (4, 150, 209),
and nitrosative stress has also been shown to be associated
with the progression of diabetic cardiomyopathy and increase
of myocardial cell death (70, 108).
Another extra-mitochondrial source of ROS in the diabetic
myocardium is the enzyme xanthine oxidase (XO) (161).
Treatment with an inhibitor of XO (allopurinol) was shown to
reduce the development of T1D-induced cardiac dysfunction
together with decreased oxidative/nitrosative stress and fi-
brosis (75, 161).
Acute and long-term effects of exercise
on ROS-producing enzymes
An acute bout of exercise will induce a cardiac stress
(acute exercise stress, [AES]) and lead to a transient increase
in reactive oxygen and nitrogen species (RONS) (26, 143,
160) (Fig. 4). This burst of RONS seems to be of utmost
importance for the cardiac response to exercise since anti-
oxidant therapies have been shown to impair health-
promoting exercise effects in healthy young humans (166)
and to impair beneficial cardiac responses in rodents (169).
Although the source of this transient increase in RONS is
not clear, rigorous cardiac contractions during intense exer-
cise have been suggested to increase the flow of electrons
through the ETC and favor increased O2
 - generation. In line
with this, Bo et al. reported an elevated ROS production in
isolated mitochondria from healthy rat hearts after prolonged
acute exercise. This was associated with a transient increase
in mitochondrial membrane potential, a marked increase in
the expression of UCP2, increased uncoupled respiration, and
reduced P/O ratio (26). Interestingly, mitochondrial ROS
production was decreased and returned to resting levels as the
exercise continued. The mitochondrial response was there-
fore regarded as ‘‘a first line of defense against ROS’’ where
(at the expense of reduced mitochondrial efficiency) allevi-
ation of mitochondrial membrane potential reduced O2
 -
generation (26).
It should be noted, however, that in the recently introduced
‘‘Redox-Optimized ROS Balance’’ (R-ORB) hypothesis (9),
where the redox environment is taken into account as an
important intermediary between mitochondrial respiration
and ROS production, increased mitochondrial respiration is
not accompanied by increased ROS, but rather by reduced
ROS (55). This questions whether the mitochondria could be
the main source of ROS during an acute exercise bout. Ac-
cordingly, several reports have suggested nonmitochondrial
ROS-producing enzymes to be activated after AES.
An acute bout of exercise was shown to induce recruitment
of catalytic subunits (p47phox and rac1) to NOX2 and increase
its activity in ventricular tissue from dogs (169) as well as to
induce a robust expression of NOX4 in mouse hearts (143).
Furthermore, exhaustive exercise was reported to acutely
increase XO activity in the myocardium of aging rats (99).
Hence, there is evidence to support that several ROS-pro-
ducing systems are activated in the heart after an AES;
however, whether these systems work together or in discrete
subcellular locations to induce specific cellular redox sig-
naling remains to be elucidated.
Long-term endurance exercise may influence ROS-
producing enzymes through very different mechanisms.
First of all, several of the exercise-mediated systemic changes
(improved insulin signaling, reduced inflammatory status,
alteration of plasma lipids, and reduced renin-angiotensin
system activity) most likely participate in decreasing ROS
in the diabetic cardiomyocyte by dampening the activators
of ROS-producing enzymes (Fig. 4). Bo et al. reported that
the exercise-induced elevation of mitochondrial ROS pro-
duction was attenuated in cardiac mitochondria from en-
durance trained rats (26), suggesting an adaptive response to
better tolerate AES in the myocardium.
In the diabetic myocardium, where chronic NOX2 acti-
vation is believed to be detrimental, long-term endurance
training significantly reduced NOX2 activity in T2D rats
(82). Although the acute effects of exercise on cardiac NOS
enzymes remain largely unexplored, long-term exercise was
shown to increase NOS expression, NO levels, and NOS
activity in healthy rat hearts (100). Such adaptations would be
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of particular benefit in the diabetic myocardium where NO
bioavailability is reduced. In accordance with this, low-in-
tensity endurance training of the T2D Goto-Kakizaki rat in-
creased myocardial eNOS protein expression and eNOS
dimer/monomer ratio, which facilitates NO generation
compared with ROS production (82).
Impaired Endogenous Antioxidant Capacity
in the Diabetic Myocardium
ROS formed is usually efficiently removed by endogenous
antioxidants in the cardiomyocyte. Diabetic hearts, however,
exhibit reduced expression and/or activity of several endog-
enous antioxidant enzymes and systems, including heme
oxygenase 1 (HO-1) (117), superoxide dismutase (SOD) (4),
catalase (195), glutathione perioxidase (GPx) (4), and the
thioredoxin (Trx) system (149). The diabetic myocardium is
also associated with a reduced ratio between reduced and
oxidized glutathione (GSH/GSSG) (5, 68, 191). Genetic ap-
proaches aimed at increasing the endogenous antioxidants
have been shown to reduce oxidative stress and rescue car-
diomyocyte contractility, cardiac morphology, and/or mito-
chondrial function in diabetic models (124, 178, 192).
An important regulator of intracellular defense against
ROS is the transcription factor Nrf2 (nuclear factor erythroid
2-related factor 2), which regulates the antioxidant response
elements (ARE) mediated expression of detoxifying and
antioxidant enzymes (106). Nrf2 stability and activity is
regulated through redox modifications of the Kelch-like
ECH-associated protein 1 (Keap1), where elevated H2O2
maintains the activation of Nrf2 (36). While acute hyper-
glycemia and short-term diabetes is associated with increased
Nrf2 activation (91), sustained ROS and long-term diabetes
seem to impair Nrf2 activity, most likely through the ERK
pathway (187).
Exercise increases myocardial antioxidant capacity
In the study of an AES, Bo et al. (26) demonstrated a time-
dependent increase in myocardial MnSOD protein and
activity, which is likely an adaptive response to minimize
exercise-induced increase in cardiac oxidative stress. Mu-
tushamy et al. (143) also demonstrated that AES induced
antioxidant defense pathways in the myocardium through
activation of Nrf2. These changes were lost in Nrf2-/- mice,
where AES resulted in increased oxidative stress and blunted
the antioxidant responses in the myocardium (Fig. 5). Al-
though there is no absolute consensus as to how endurance
exercise influences antioxidant systems in the healthy heart,
most studies have reported increased or unchanged gene
expressions of antioxidant enzymes and systems after both
long and short-term endurance training (11).
As the diabetic myocardium is associated with impaired
antioxidant capacity, one would expect that exercise training
could be particularly beneficial to the diabetic heart through
enhancement of the myocardial antioxidant systems. Despite
few studies on this issue, increased gene and protein ex-
pression of myocardial antioxidant systems have been re-
ported in endurance trained diabetic and obese models (68,
85). Increased exercise-induced insulin sensitivity could
potentially increase Nrf2 activity, as insulin signaling has
been shown to increase myocardial Nrf2 activity via the PI3K
pathway (187) (Fig. 5).
Finally, the progression and the severity of diabetes may be
an important determination in how the diabetic heart tolerates
and adapts to an AES and endurance training. Short-term (2
weeks) intense exercise of old and severely diabetic db/db
mice using motorized wheels failed to induce the same an-
tioxidant responses as seen in the myocardium of their con-
trol littermates (119). These hearts also exhibited reduced
GSH/GSSG ratio, increased 4HNE content, and elevated fi-
brosis compared with untrained mice (119). Although not
addressed or discussed in this article, this observation could
be related to an impaired Nrf2 induction after the long-term
diabetes (187). It could also be speculated that the use of
motorized running wheels induced a considerable greater
stress on the animals as compared with the use of treadmills
or nonmotorized wheels where the animals can engage in
more normal running behavior.
Autophagy in Diabetic Cardiomyopathy
and the Potential Effects of Exercise
Elevated levels of nitrosative and oxidative stress are also
believed to contribute to the disruption of autophagy that has
been reported in diabetic cardiomyopathy and in hearts from
rodents fed obesogenic diets (42, 194). Autophagy is viewed
as a housekeeping process to maintain cellular homeostasis
and is essential for the removal of protein and lipid aggre-
gates, damaged and unwanted organelles. As the diabetic
heart is more prone to adverse molecular modifications of
FIG. 5. Proposed effects of exercise on endogenous
antioxidant responses in the diabetic myocardium. In
long-term diabetes, sustained reactive oxygen species (ROS)
and impaired insulin signaling may lead to impaired nuclear
factor erythroid 2-related factor 2 (Nrf2) activity due to
exaggerated phosphorylation of the extracellular signal-
related kinase (ERK) and reduced activity of phosphoino-
sitol 3-kinase (PI3K). This may lead to reduced endogenous
antioxidant capacity and oxidative stress, here illustrated by
the ratio of reduced glutathione (GSH) to oxidized gluta-
thione (GSSG). Acute exercise leads to a transient increase
in reactive oxygen and nitrogen species (RONS) that sta-
bilize and activate Nrf2, leading to transcriptional increase
in endogenous antioxidant systems. Endurance training
with repetitive bouts of RONS and improved insulin sig-
naling can increase Nrf2 activity, which increases the an-
tioxidant capacity of the myocardium. In conditions of
impaired Nrf2 signaling and blunted antioxidant responses,
exercise stress may lead to increased oxidative stress. See
‘‘Impaired Endogenous Antioxidant Capacity in the Dia-
betic Myocardium’’ section for references.
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proteins and lipids, impaired autophagy may be particularly
harmful and thus a potential contributor to the development
of diabetic cardiomyopathy (194). Autophagy has been
shown to be an important adaptive response that counteracts
the development of insulin resistance in response to a high-fat
diet in mice, and loss of autophagy was shown to impair
insulin action in obese mice (59).
Acute exercise has been demonstrated to induce autophagy
both in skeletal and in cardiac muscle (90). Interestingly, both
short- and long-term exercise has been shown to improve
insulin sensitivity through an autophagy-dependent mecha-
nism (90). Whether endurance exercise can amend blunted
autophagy in diabetic myocardium is yet to be explored.
Altered Calcium Handling in the Diabetic
Cardiomyocyte
Changes in intracellular Ca2 + handling are believed to be
an important factor leading to ventricular dysfunction in di-
abetes. At the cellular level, diabetic cardiomyocytes are
characterized by Ca2 + transients with lower amplitude and
slower rate of decay, which is linked to impaired Ca2 +
handling by the sarcoplasmic reticulum (SR) (Fig. 6). A re-
duced SERCA2a activity (18, 176, 184) most likely con-
tributes to both diastolic and systolic dysfunction in diabetes,
as it may lead to impaired SR Ca2 + release and reuptake and,
subsequently, reduced SR Ca2 + load. Although the exact
mechanisms behind these alterations are not fully elucidated,
studies have reported a decrease in SERCA2a expression
and/or changes in its regulator phospholamban (PLN) (18,
61, 114, 121, 152).
Due to its slow turnover rate, SERCA2a is susceptible to
post-translational modifications. An extensive SERCA2a
glycation has been reported in the myocardium of STZ-
induced diabetic rats (20), and treatment with the AGE cross-
link breaker was found to partially normalize SR Ca2 +
handling and cardiac function in an STZ model (114). In-
creased O-GlcNAcylation of PLN, SERCA2a and its tran-
scription factor Sp1 have also been shown to be involved
in myocardial SERCA2 downregulation and dysfunction
after exposure to high glucose and in diabetes (52, 69). Al-
though not extensively studied in diabetes, redox regulation
of SERCA2a may also play a role, as ROS has been shown
to reduce SERCA2a pump activity in heart failure (51).
It has also been shown that the decreased expression and
function of SERCA2a is accompanied by an increased NCX
expression and function in the diabetic myocardium (121,
184), which most likely serve as a compensatory mechanism
to lower cytoplasmic Ca2 + levels. Furthermore, diabetic
cardiomyocytes display increased SR Ca2 + leak through
ryanodine receptors (RyR2) (16, 184), which may contribute
toward reducing SR Ca2 + content. This does not seem to be
associated with increased RyR2 protein expression (61, 152,
163, 184), but rather to altered RyR phosphorylation status
due to changes in the activity of upstream kinases (149, 163,
176). O-GlcNAc-modified CaMKII was recently demon-
strated in the heart of diabetic humans and rats by Erickson
et al. (63), linking diabetic hyperglycemia to increased SR
Ca2 + release events. In accordance with this, SR Ca2 + leak
was normalized after inhibition of CaMKII in db/db cardio-
myocytes (184).
Another plausible mediator of this SR Ca2 + leak is ROS, as
it can increase the activity of upstream kinases such as PKA
and CaMKII (35, 62). Oxidation of RyR2 can also promote
increased opening probability of the channel and, conse-
quently, promote Ca2 + leak (58). Increased spontaneous
Ca2 + spark frequency and dyssynchronous Ca2 + release, in
addition to reduced transverse (T)-tubule density, has also
been reported in cardiomyocytes from db/db mice (184).
The diabetic myocardium is associated with an altered
adrenergic contractile response due to reduced density of
b-adrenoceptors (b-AR) (93), impaired b-adrenergic G-
protein-adenylat cyclase system, and PLN phosphorylation
(21, 73). Recent studies also suggest a cross-talk between IR
activation and the b-AR2, where the contractile response to
cardiac b-adrenergic stimuli was blunted through a b2AR-
dependent mechanism (71).
It should be stressed that a common limitation in studies
addressing calcium transport in cardiomyocytes is the lack of
FAs as energy substrates. The diabetic cardiomyocyte most
likely is adapted to and potentially dependent on FAs as an
energy substrate. This notion is supported by studies showing
that the addition of FA as a substrate significantly increases
Ca2 + transients in diabetic cardiomyocytes (64, 191).
Exercise improves calcium homeostasis
Exercise training has been shown to improve cardiomyo-
cyte contractility in obese/diabetic models, changes that have
been associated with improved Ca2 + homeostasis (61, 137,
FIG. 6. Impaired calcium homeostasis in diabetic car-
diomyocyte is improved by exercise training. In diabetes,
Ca2 + transients are altered due to impaired SERCA2a
function and increased RyR2 Ca2 + leak. These cardio-
myocytes are also more dependent on SL Ca2 + transport,
have increased spontaneous Ca2 + spark frequency, dyssyn-
chronous Ca2 + release, and reduced T-tubule density, as well
as reduced b-adrenergic response. Mitochondrial Ca2 + cy-
cling via the uniporter entry system (mCU) is essential in the
activation of key metabolic enzymes. Indicated by stars are
exercise-induced changes after endurance training in models
of obesity/diabetes that may contribute to restoring myocar-
dial Ca2 + homeostasis (see text for details and references).
NKA, Na+ /K+ ATPase; PLN, phospholamban: b-AR, b-
adrenergic receptor; TCA, tricarboxylic acid; PDH, pyruvate
dehydrogenase complex: cMyBp, cardiac myosin binding
protein C. SL, sarcolemmal; SR, sarcoplasmatic reticulum;
RyR2, ryanodine receptor 2 SERCA2a, SR Ca2 + ATPase;
NCX, Na+ /Ca2 + exchange; PMCA, SL Ca2 + ATPase.
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184). Exercise effectively restored myocardial expression
and activity of SERCA2a (19, 61, 176, 184), associated with
an increase in PLN phosphorylation at the Serine 16 (61,
184). In addition, exercise normalized the diabetic-induced
Ca2 + SR leak in cardiomyocytes from db/db mice (184) and
STZ rats (176). The reduced leak does not seem to be linked
to altered RyR2 expression (61, 152, 176, 184) but rather to
its phosphorylation status due to a normalization of CaMKII
activity (176, 184). Stabilization of the RyR was also found to
restore the synchronicity of SR Ca2 + release (184). In addi-
tion, Stolen et al. (184) reported that high-intensity interval
training restored T-tubule density, which by improving the
spacing between L-type Ca2 + channels and RyR2 may im-
prove the efficiency of EC coupling.
Clinical studies have demonstrated that exercise inter-
ventions after the onset of diabetes can improve the re-
sponsiveness of the heart to b-adrenergic stimulation (196).
In experimental models, this has been shown to be associ-
ated with preserved levels of b-adrenoceptors (21, 137).
Finally, exercise-induced improvement of function in dia-
betic hearts may also be related to PKA-induced phos-
phorylation of the myofibrillar proteins troponin I and
myosin-binding protein-C (111).
Cardiac Inefficiency and Oxygen Wasting in Diabetes
Despite its high metabolic activity, the heart has a relatively
low content of high energy compounds. Consequently, the
heart depends on optimal substrate metabolism and efficient
ATP hydrolysis at energy consuming sites. Any imbalance
between energy demand and availability can ultimately lead to
an energetically compromised heart with reduced working
capacity. In support of this notion, decreased myocardial en-
ergetics, measured as a reduced PCr:ATP ratio, has been
shown to correlate with the severity of heart failure in patients
with idiopathic dilated cardiomyopathy (146). Decreased
PCr:ATP ratio has also been reported in hearts from obese and/
or T2D subjects (154, 171), and impaired cardiac energetics
due to cardiac inefficiency has been suggested to be an im-
portant mediator in the progression of obesity/diabetes-in-
duced cardiac dysfunction.
Reduced cardiac mechanical efficiency, defined as the
ratio between external work (stroke work) and MVO2 (23),
has become a hallmark of the obese/diabetic heart, as it has
been reported in a range of experimental studies (1, 32, 38,
53, 68, 85, 201) as well as in obese young women (155).
Impaired mechanical efficiency also precedes the develop-
ment of obesity/diabetes-related ventricular dysfunction (85,
155, 201).
A range of factors are known to determine MVO2; apart
from heart rate, this includes factors related to the energy
used for generating force/tension by the contractile machin-
ery (i.e., pre- and after-load) and factors related to nonme-
chanical processes. It should be noted that mechanical
efficiency is a load-dependent parameter and that afterload-
dependent peak efficiency was not found to be affected in
STZ-induced diabetes (87).
The underlying mechanisms leading to decreased effi-
ciency in diabetic cardiomyopathy are far from clear. It is
acknowledged that an acute elevation of FAs in the normal
heart induces oxygen wasting (28, 53, 95, 138), and as FA is a
less efficient substrate when compared with glucose (lower
P/O ratio), increased FA oxidation is generally suggested to
be causative for this increase in MVO2. Likewise, elevated
FA oxidation in the diabetic heart is also regarded to be an
important factor leading to decreased mechanical efficiency.
It should be noted, however, that the heart should only use
11–12% more MVO2 when shifted from exclusively glucose
to FA oxidation, which is too low to explain the reported
increase in MVO2 under both increased FA load and diabetes
where the change in substrate utilization is far less (95, 138).
Supporting the notion that additional oxygen consuming
processes are activated are experimental data indicating that
it is not the high myocardial FA oxidation rate (accompa-
nying elevated FA concentration) that leads to the increased
MVO2 in normal hearts (28, 102), but that FAs increase the
nonwork-related oxygen demand for processes associated
with EC coupling (28, 41). In contrast to what is observed in
normal hearts, exposing hearts from T2D mice to high FA
levels does not further increase MVO2 (despite elevation of
FA oxidation rates) (28, 53, 95). Taken together, it is clear
that the oxygen wasting effects of acute and a more long-term
elevation of FAs levels are not necessarily via the same
mechanisms and, importantly, FA oxidation rates per se do
not seem to be the sole mechanism for the increased MVO2.
Assessment of left ventricular mechanoenergetic proper-
ties [by using the PVA-MVO2 framework (186)] has dem-
onstrated that the diabetic heart uses more oxygen for
nonmechanical processes (84, 85, 95), including processes
associated with basal metabolism and EC coupling (27, 28,
85). The energy cost for EC coupling is primarily related to
calcium transport, and changes in myocardial Ca2 + handling
in the diabetic heart may therefore contribute to the observed
increase in the oxygen cost of EC coupling. Oxygen wasting
processes may include SR Ca2 + leak (16, 184) and subse-
quent futile cycling of Ca2 + , increased use of the less ener-
getically favorable NCX instead of SERCA2a for
cytoplasmic Ca2 + clearance, as well as dyssynchronous SR
Ca2 + release (181).
In addition, increased ventricular stiffness (and thus wall
stress) can occur due to diabetes-induced fibrosis (101) and
excessive accumulation of AGEs (114) may also contribute
to a decreased mechanical efficiency in the diabetic heart.
Myocardial oxygen consumption has been found to be cor-
related with levels of ROS in cardiac tissue (85), which
suggests that oxidative stress may play a role in diabetes-
induced oxygen wasting. In support of this, although not
addressed in the diabetic myocardium, allopurinol (a XO
inhibitor) infusion to heart failure patients significantly in-
creased cardiac mechanical efficiency (44).
Exercise restores cardiac efficiency through oxygen
sparing effects
Improved cardiac efficiency after endurance training is
supported by studies done on patients with dilated cardio-
myopathy (183, 193) and in a swine model of heart failure
with a preserved ejection fraction (132). Recently, exercise
training was also shown to improve mechanical efficiency
due to reduced oxygen consumption for both basal metabo-
lism and EC coupling in hearts from diet-induced obese mice
(85). The exercise-induced reduction in oxygen wasting as-
sociated with EC coupling can be related to reduced RyR2
Ca2 + leak, improved SERCA2a function and normalization
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of SL Ca2 + transport, and synchronization of SR Ca2 + re-
lease. It is known that calcium-handling proteins are sensitive
to the intracellular redox environment (35, 51, 58, 62), and it
is, therefore, tempting to suggest that the reported positive
correlation between myocardial ROS and MVO2 (85) reflects
ROS-mediated changes in Ca2 + handling.
In addition, as exercise has been found to counteract
obesity-induced left ventricular remodeling and to reduce
ventricular fibrosis (85, 119, 128, 167); a reduced wall stress
can also positively affect cardiac efficiency. Finally, as de-
creased efficiency will be particularly disadvantageous under
conditions of reduced oxygen availability, one could also
speculate that exercise-induced amendments of cardiac effi-
ciency could also reduce ischemic susceptibility in the dia-
betic heart.
Concluding Remarks
Cardiovascular disease is the leading cause of mortality in
people with diabetes, and there is no doubt that exercise
training is efficient in the prevention and treatment of obesity
and T2D. Exercise influences several of the systemic changes
associated with diabetes/obesity such as insulin resistance,
glycemic control, plasma lipid levels, and inflammatory
status, and beneficial cardiac effects after exercise training in
this patient group are reported.
Due to the complex nature of the development of T2D, the
diversity of exercise training regimens, and wide range of
physiological adaptations to exercise, it is not unexpected
that reports regarding the mechanisms that may lead to the
cardiac response to exercise training are diverging. In addi-
tion, studying molecular adaptions to exercise in the diabetic
heart advocates the use of animal models where the severity
and the progression of diabetes may vary, which may influ-
ence the tolerance and the adaptive response to acute and
chronic exercise. It is essential that the models used in ex-
perimental studies of T2D closely resemble those of the hu-
man disease, and that changes in STZ-induced T1D models
do not necessarily reflect the changes in obese T2D models. It
is also likely that variations in animal diets can influence the
adaptive response to exercise and the restitution between
exercise sessions.
In many exercise studies, it is challenging to discriminate
between the indirect effects linked to exercise-mediated
systemic changes and the direct cardiac effect originating
from the high contractile activity of the heart during bouts of
physical training. In addition, there are clearly different
molecular pathways involved in the cardiac response to an
AES as opposed to the adaptive changes after repetitive bouts
of high contractile activity during physical training. More-
over, there are most likely transient time-dependent changes
during the cardiac adaptive responses to exercise.
The different training regimens with respect to exercise
mode, duration, and intensity between studies may also cause
discrepancies between findings. For instance, experimental
and clinical studies have suggested that exercise interven-
tions with higher intensities produce greater effects in terms
of improving glycemic control and insulin sensitivity (85,
190, 200). High-intensity training has also been shown to
produce greater aerobic capacity (92) and to produce greater
cardiac adaptations than isocaloric low-moderate intensity
training (83, 110).
Few experimental studies actually report how fitness and
aerobic capacity are affected by the exercise protocols, and
the role of exercise intensity in the adaptive responses in the
diabetic heart is not well elucidated. As low aerobic capacity
is a strong predictor of cardiovascular disease (25, 109), it
would be a great advantage if the effect of the exercise regime
used on VO2max was reported in experimental studies.
The beneficial cardiac effects of exercise in diabetic car-
diomyopathy is supported by studies reporting exercise
training to amend many of the metabolic disturbances char-
acterizing the diabetic myocardium, including mitochondrial
capacity and efficiency, carbohydrate oxidation, lipotoxicity,
and disturbances in nonoxidative glucose pathways. In ad-
dition, direct and systemic effects of exercise training may
influence ROS production and enhance endogenous antioxi-
dant capacity, making exercise intervention a potent tool in
amending the pro-oxidant milieu of the diabetic heart. Ex-
ercise-induced improvements of myocardial calcium han-
dling are also of great therapeutic potential in the diabetic
heart, as they may improve ventricular function, cardiac ef-
ficiency, and potentially also mitochondrial function. Re-
vealing the molecular mechanisms behind the beneficial
effects of exercise training is of considerable scientific value
to generate evidence-based therapy and in the development
of new therapeutic strategies.
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AES¼ acute exercise stress
AGEs¼ advanced glycation end-products
ANT¼ adenine nucleotide translocator
AR¼ aldose reductase
ARE¼ antioxidant response elements
CaMKII¼Ca2+-calmodulin-dependent protein
kinase II
cMyBp¼ cardiac myosin binding protein C




DGAT1¼ diacylglycerol transferase 1
EC¼ excitation-contraction
eNOS¼ endothelial NOS
ERK¼ extracellular signal regulated kinase
ETC¼ electron transport chain
FA¼ fatty acids
FABP¼ fatty acid binding protein
FAT/CD36¼ fatty acid translocase
FATP¼ fatty acid transport protein






HBP¼ hexosamine biosynthetic pathway
HK¼ hexokinase
HO-1¼ includes heme oxygenase 1
iNOS¼ inducible NOS
IR¼ insulin receptor
IRS-1¼ insulin receptor substrate-1
IRS-2¼ insulin receptor substrate-2
JNK¼ c-Jun N-terminal kinase





MnSOD¼manganese superoxide dismutase 0
mPTP¼mitochondrial permeability transition pore
MVO2¼myocardial oxygen consumption











PDH¼ pyruvate dehydrogenase complex
PDK4¼ pyruvate dehydrogenase kinase 4
PI3K¼ phosphatidylinositol-4,5-bisphosphate
3-kinase
PKC¼ protein kinase C
Plin-5¼ perilipin-5
PLN¼ phospholamban
PMCA¼ sarcolemmal Ca2+ ATPase
PPAR-a¼ peroxisomal proliferator activated
receptor- a
PVA¼ pressure volume area
RAGEs¼AGE receptors
RAS¼ renin-angiotensin system
RCR¼ respiratory control ratio
RONS¼ reactive oxygen and nitrogen species
ROS¼ reactive oxygen species
RyR2¼ ryanodine receptors
Serca¼ sarcoplasmic reticulum Ca2+ ATPase




sRAGE¼ soluble form of RAGE
STZ¼ streptozytocin
T1D¼ type 1 diabetes
T2D¼ type 2 diabetes
TAG¼ triglyceride
UCP¼ uncoupling proteins
UDP-GlcNAc¼ uridine diphosphate N-acetylglucosamine
VO2max¼maximal oxygen uptake
XO¼ xanthine oxidase
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